AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Which Index Funds Had Best Yearly Returns Historically reveals top performers by year, helping you compare success across funds.
25,767 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Mega-cap AI bets are fueling a surge in debt issuance this year, prompting fresh debate over whether the AI expansion...
This article breaks down Summit Hotel (Inn) earnings, translating quarterly results into actionable insights for inve...
Texas Instruments preps for July earnings with a guidance-led breakout in industrial and data-center demand, plus a f...
PSEG's steady, regulated core supports its payout, but 2025 earnings hinge on rate cases, fuel costs, and clean energ...
Jamie Dimon's JPMorgan Chase just delivered a striking quarterly message: big gains in equities trading and a higher ...
A new wave of consumer action challenges Big Tech by urging people to purge subscriptions and rethink their spending ...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...
As energy demand grows, NuScale Power offers a potential long-term angle with small modular reactors. This guide expl...
Investors are debating whether Microsoft stock is undervalued. This guide breaks down the fundamentals, growth cataly...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...
New IRS data summarized by the Kiplinger Letter shows the ultra-wealthy paid a 23.61% effective federal tax rate in 2...